SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027012
Filing Date
2021-05-12
Accepted
2021-05-12 16:18:38
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-10q_20210331.htm 10-Q 1744471
2 EX-31.1 sprb-ex311_7.htm EX-31.1 20256
3 EX-31.2 sprb-ex312_9.htm EX-31.2 18882
4 EX-32.1 sprb-ex321_8.htm EX-32.1 8421
5 EX-32.2 sprb-ex322_6.htm EX-32.2 9675
  Complete submission text file 0001564590-21-027012.txt   4656677

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sprb-20210331.xml EX-101.INS 632586
7 XBRL TAXONOMY EXTENSION SCHEMA sprb-20210331.xsd EX-101.SCH 41142
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sprb-20210331_cal.xml EX-101.CAL 31069
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sprb-20210331_def.xml EX-101.DEF 113529
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sprb-20210331_lab.xml EX-101.LAB 318090
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sprb-20210331_pre.xml EX-101.PRE 233820
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 21915372
SIC: 2834 Pharmaceutical Preparations